Aclaris Therapeutics, Inc. (ACRS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 3.5M 7M 10.5M Q3 '24: 4.3M Q4 '24: 9.2M Q1 '25: 1.5M Q2 '25: 1.8M Q3 '25: 3.3M Q4 '25: 1.3M Q1 '26: 2M Q2 '26: 1.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 900K 1.8M 2.7M Q3 '17: 231K Q4 '17: 245K Q1 '18: 151K Q2 '18: 2.5M Q3 '18: 435K Q4 '18: 160K Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18

Operating Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '24: -10.5M Q4 '24: -99.7M Q1 '25: -18.1M Q2 '25: -18.4M Q3 '25: -17.1M Q4 '25: -22.7M Q1 '26: -22.2M Q2 '26: -24.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '24: -7.6M Q4 '24: -96.6M Q1 '25: -15.1M Q2 '25: -15.4M Q3 '25: -14.6M Q4 '25: -19.8M Q1 '26: -19.8M Q2 '26: -21.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q3 '24: 654K Q4 '24: 705K Q1 '25: 506K Q2 '25: 515K Q3 '25: 538K Q4 '25: 532K Q1 '26: 395K Q2 '26: 218K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '24: 22M Q4 '24: -8.9M Q1 '25: -13.1M Q2 '25: -10M Q3 '25: -10.9M Q4 '25: -13.1M Q1 '26: -18.1M Q2 '26: -19.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '24: 22M Q4 '24: -8.9M Q1 '25: -13.1M Q2 '25: -10M Q3 '25: -11M Q4 '25: -13.2M Q1 '26: -18.2M Q2 '26: -19.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 71.1M Q2 '24: 71.3M Q3 '24: 71.4M Q1 '25: 122.4M Q2 '25: 122.6M Q3 '25: 122.6M Q1 '26: 128.8M Q2 '26: 142.7M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '24: -0.52 Q4 '24: -1.71 Q1 '25: -1.59 Q2 '25: -1.57 Q3 '25: -1.58 Q4 '25: -0.53 Q1 '26: -0.56 Q2 '26: -0.58 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.